The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capita bumps up forecast for 2016 dividends, mid-caps to take Brexit hit

Mon, 18th Jul 2016 12:28

(ShareCast News) - The fall in sterling following Brexit would deliver an immediate boost to the value of companies' dividend payments but potential recessionary pressures would hit profits and dividends from UK-focused mid-caps hardest, Capita said in its second quarter 2016 Dividend Monitor. Despite that, the business process outsourcing company revised its headline dividend forecast for 2016 higher by 3.8% to £82.5bn, as a result of the 'windfall' from special dividends.UK dividend payouts rose by a record £28.8bn in the second quarter (Q2), marking a 7.6% rise in comparison to a year ago.That increase surpassed the previous record established in the first quarter of 2014, when Vodafone distributed a record payment in the wake of the sale of its stake in Verizon Wireless.However, the main reason for the jump in payouts was a flurry of special dividend payments - from a wide range of sectors - which more than quadrupled to £3.5bn.InterContinental Hotels led the way, paying out £1.0bn, followed by GlaxoSmithKline with another £970m.A total of 22 companies paid special dividends in the second quarter, the biggest number on record, although by value it was the third biggest total ever.Underlying dividends, on the other hand, decreased by 2.7% year-on-year to £25.2bn, despite a £960m gain in the value of dividends declared in US dollars and euros as the pound weakened ahead of the referendum vote.Very low levels of dividend coverDividends had held up much better than company profits over the last couple of years, Capita said, but that meant that dividend cover had fallen to very low levels."Inevitably, dividend growth is difficult to sustain in those circumstances, and this explains why the underlying picture is weak," it said.The financial sector was the largest payer in Q2, despite a cancellation from StanChart and a cut at Barclays. Life insurers and Lloyds were particularly strong.HSBC remained in the top spot in Q2, making up 10% of the total, while Lloyds Bank nudged into the top 5 for the first time since 2008.The top 5 dividend payers - HSBC, Barclays, Lloyds, BP and Royal Dutch Shell - made up 38% of the Q2 payouts, their biggest share since 2011.Dividends from mid-caps fell 5.5% to £3.6bn, albeit mainly reflecting changes to the index constituents."It's clear that mid-cap company dividends have continued to outpace their larger counterparts. For now at least," Capita said.Indeed, Capita forecast future dividends would take a hit from Brexit.Offsettinig that to an extent, Capita forecast that UK equities would yield 3.7% over the next twelve months, outpacing the 1.4% offered by cash savings accounts or the 3.4% on offer from UK property yields net of costs.Furthermore, Capita pointed out, for UK taxpayers the first £5,000 of dividend income was tax-free.
More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.